Last update at 2025-06-12T13:30:00Z
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
Form 8.3 - Assura plc - Amendment
Mon 19 May 25, 03:27 PMTrending tickers: Nvidia, Alibaba, Novavax, Ryanair and Diageo
Mon 19 May 25, 10:00 AMFTSE 100 recovers to pre-trade tariff announcement levels
Fri 16 May 25, 04:06 PMNHS landlord Assura attracts new offer from PHP as bidding war heats up
Fri 16 May 25, 01:28 PMGP surgeries owner Assura agrees to private equity takeover worth £1.61bn
Wed 09 Apr 25, 07:00 AMUK's Assura agrees to $2.06 billion takeover by KKR-Stonepeak
Wed 09 Apr 25, 06:21 AMUK's Assura shares rise on $2.08 billion bid from KKR, Stonepeak
Mon 10 Mar 25, 07:22 AMUK's Assura rejects $2 billion buyout bid from KKR, pension fund
Mon 17 Feb 25, 07:32 AMBreakdown | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 |
Income before tax | -119.20000M | 155.80M | 108.30M | 78.90M | 84.00M |
Minority interest | - | - | - | - | - |
Net income | -119.20000M | 155.90M | 108.30M | 78.90M | 84.00M |
Selling general administrative | 13.30M | 11.70M | 13.50M | 9.90M | 8.70M |
Selling and marketing expenses | - | - | - | - | - |
Gross profit | 138.00M | 126.50M | 112.00M | 103.70M | 95.20M |
Reconciled depreciation | - | - | - | - | - |
Ebit | - | 114.10M | 100.50M | 93.60M | 86.20M |
Ebitda | -91.70000M | 182.30M | 132.40M | 103.60M | 105.30M |
Depreciation and amortization | - | - | - | - | - |
Non operating income net other | - | - | - | - | - |
Operating income | -91.70000M | 182.30M | 132.40M | 103.60M | 105.30M |
Other operating expenses | 26.40M | 22.80M | 22.80M | 17.90M | 16.20M |
Interest expense | 26.80M | 26.50M | 24.10M | 24.70M | 21.30M |
Tax provision | 0.00000M | -0.10000M | 0.00000M | 0.00000M | 0.00000M |
Interest income | 1.60M | 0.40M | 0.20M | 0.00000M | 0.10M |
Net interest income | -27.30000M | -28.00000M | -32.20000M | -26.10000M | -22.40000M |
Extraordinary items | - | - | - | - | - |
Non recurring | - | - | - | - | - |
Other items | - | - | - | - | - |
Income tax expense | - | -0.10000M | - | - | - |
Total revenue | 150.40M | 136.90M | 120.80M | 111.50M | 102.40M |
Total operating expenses | 14.00M | 12.40M | 14.00M | 10.10M | 9.00M |
Cost of revenue | 12.40M | 10.40M | 8.80M | 7.80M | 7.20M |
Total other income expense net | -27.50000M | -26.50000M | -24.10000M | -24.70000M | -21.30000M |
Discontinued operations | - | - | - | - | - |
Net income from continuing ops | -119.20000M | 155.90M | 108.30M | 78.90M | 84.00M |
Net income applicable to common shares | - | 155.90M | 108.30M | 78.90M | 84.00M |
Preferred stock and other adjustments | - | - | - | - | - |
Breakdown | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 |
Total assets | 2812.20M | 2922.60M | 3120.50M | 2557.10M | 2209.30M |
Intangible assets | - | - | - | - | - |
Earning assets | - | - | - | - | - |
Other current assets | 19.20M | 2.30M | 77.90M | 16.40M | 22.00M |
Total liab | 1339.10M | 1335.10M | 1330.90M | 1026.40M | 906.90M |
Total stockholder equity | 1473.10M | 1587.50M | 1789.60M | 1530.70M | 1302.40M |
Deferred long term liab | - | - | - | - | - |
Other current liab | 76.50M | 30.60M | 30.10M | 25.40M | 22.80M |
Common stock | 298.50M | 296.10M | 294.80M | 267.20M | 241.30M |
Capital stock | 298.50M | 296.10M | 294.80M | 267.20M | 241.30M |
Retained earnings | 10.90M | 135.30M | 345.10M | 269.20M | 234.40M |
Other liab | - | - | 6.00M | 6.10M | 4.80M |
Good will | - | - | - | - | - |
Other assets | - | - | 0.60M | 0.50M | 0.50M |
Cash | 33.20M | 118.00M | 243.50M | 46.60M | 18.50M |
Cash and equivalents | - | - | - | - | - |
Total current liabilities | 82.40M | 77.80M | 75.10M | 66.20M | 66.10M |
Current deferred revenue | - | - | - | - | - |
Net debt | 1219.60M | 1134.60M | 1006.40M | 907.60M | 828.60M |
Short term debt | 0.30M | 0.40M | 0.10M | 0.10M | 11.10M |
Short long term debt | - | - | - | 0.00000M | 11.00M |
Short long term debt total | 1252.80M | 1252.60M | 1249.90M | 954.20M | 847.10M |
Other stockholder equity | 932.70M | 1156.10M | 1149.70M | 994.30M | 826.70M |
Property plant equipment | - | - | 2767.60M | 2467.20M | 2150.30M |
Total current assets | 73.10M | 151.50M | 348.50M | 88.70M | 58.30M |
Long term investments | - | - | - | - | - |
Net tangible assets | - | - | 1789.60M | 1530.70M | 1302.40M |
Short term investments | - | - | - | - | - |
Net receivables | 20.70M | 33.10M | 27.20M | 26.00M | 18.00M |
Long term debt | 1246.90M | 1246.40M | 1244.40M | 948.70M | 830.50M |
Inventory | 0.00000M | - | - | - | - |
Accounts payable | 1.70M | 46.80M | 44.90M | 40.70M | 32.20M |
Total permanent equity | - | - | - | - | - |
Noncontrolling interest in consolidated entity | - | - | - | - | - |
Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
Accumulated other comprehensive income | 231.00M | - | - | - | - |
Additional paid in capital | - | - | - | - | - |
Common stock total equity | - | - | - | - | - |
Preferred stock total equity | - | - | - | - | - |
Retained earnings total equity | - | - | - | - | - |
Treasury stock | - | - | - | - | - |
Accumulated amortization | - | - | - | - | - |
Non currrent assets other | 2718.40M | 2770.20M | 2770.90M | 2467.60M | 2150.30M |
Deferred long term asset charges | - | - | - | - | - |
Non current assets total | 2739.10M | 2771.10M | 2772.00M | 2468.40M | 2151.00M |
Capital lease obligations | 5.90M | 6.20M | 5.50M | 5.50M | 5.60M |
Long term debt total | - | - | - | - | - |
Breakdown | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2023-03-31 | 2022-03-31 | 2021-03-31 | 2020-03-31 | 2019-03-31 |
Investments | -130.40000M | -3.50000M | -0.70000M | -0.20000M | -0.20000M |
Change to liabilities | 0.00000M | 0.00000M | 0.00000M | 0.00000M | 0.00000M |
Total cashflows from investing activities | - | -293.90000M | -267.50000M | -166.20000M | -224.20000M |
Net borrowings | - | 295.90M | 108.10M | 157.00M | 198.40M |
Total cash from financing activities | -89.20000M | 396.20M | 218.20M | 100.10M | 140.90M |
Change to operating activities | 1.20M | 8.40M | 9.50M | 3.90M | 8.70M |
Net income | -119.20000M | 155.90M | 108.30M | 78.90M | 84.00M |
Change in cash | -125.50000M | 196.90M | 28.10M | 0.20M | -10.40000M |
Begin period cash flow | 243.50M | 46.60M | 18.50M | 18.30M | 28.70M |
End period cash flow | 118.00M | 243.50M | 46.60M | 18.50M | 18.30M |
Total cash from operating activities | - | 94.60M | 77.40M | 66.30M | 72.90M |
Issuance of capital stock | 0.00000M | 182.60M | 186.00M | - | 0.00000M |
Depreciation | 0.20M | 0.20M | 0.10M | 0.10M | 0.20M |
Other cashflows from investing activities | - | - | - | - | - |
Dividends paid | -88.90000M | -75.40000M | -61.90000M | -56.60000M | 55.00M |
Change to inventory | - | - | - | - | - |
Change to account receivables | -4.40000M | -0.90000M | -5.20000M | -5.80000M | -0.80000M |
Sale purchase of stock | - | - | 290.50M | - | - |
Other cashflows from financing activities | -0.30000M | 309.00M | 284.10M | 156.70M | 295.90M |
Change to netincome | 214.20M | -70.90000M | -36.90000M | -12.20000M | -20.40000M |
Capital expenditures | 57.90M | 63.70M | 57.60M | 53.70M | 21.20M |
Change receivables | - | - | - | - | - |
Cash flows other operating | - | - | - | - | - |
Exchange rate changes | - | - | - | - | - |
Cash and cash equivalents changes | - | - | - | - | - |
Change in working capital | - | - | - | - | - |
Stock based compensation | - | - | - | - | - |
Other non cash items | - | - | - | - | - |
Free cash flow | -57.90000M | -63.70000M | -57.60000M | -53.70000M | -21.20000M |
Sector: Real Estate Industry: REIT - Healthcare Facilities
Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
---|---|---|---|---|---|---|---|---|
ARSSF Assura Plc |
- -% | 0.64 | 17.63 | 11.21 | 7.62 | 0.84 | 17.55 | 29.71 |
WELL Welltower Inc |
-0.16 0.11% | 151.75 | 170.68 | 72.46 | 7.75 | 2.13 | 9.77 | 27.67 |
VTR Ventas Inc |
-0.17 0.27% | 63.55 | 2524.00 | 25.51 | 4.47 | 1.98 | 7.44 | 17.76 |
OHI Omega Healthcare Investors Inc |
-0.08 0.22% | 36.94 | 31.33 | 10.13 | 9.06 | 2.05 | 14.35 | 15.26 |
HR Healthcare Realty Trust Incorporated |
0.16 1.07% | 15.07 | - | 10.83 | 4.82 | 0.93 | 8.92 | 15.95 |
Assura plc is a national healthcare premises specialist and UK REIT based in Altrincham, UK - caring for more than 600 primary healthcare buildings, from which over six million patients are served. A constituent of the FTSE 250 and the EPRA indices, as at 30 September 2023, Assura's portfolio was valued at £2.7 billion. At Assura, we BUILD for health. Assura builds better spaces for people and places, invests in skills and inspires new ways of working, and unlocks the power of design and innovation to deliver lasting impact for communities - aiming for six million people to have benefitted from improvements to and through its healthcare buildings by 2026. Assura is leading for a sustainable future, targeting net zero carbon across its portfolio by 2040.
3 Barrington Road, Altrincham, United Kingdom, WA14 1GY
Name | Title | Year Born |
---|---|---|
Mr. Jonathan Stewart Murphy ACA, MBA | CEO & Exec. Director | 1972 |
Ms. Jayne Marie Cottam | CFO & Exec. Director | 1974 |
Ms. Amanda Roddy | Sr. Investment Mang. | NA |
Ms. Joanne Cullen | Sr. Management Accountant | NA |
Mr. David Purcell | Head of Investor Relations | NA |
Ms. Orla Ball | Head of Legal & Company Sec. | NA |
Ms. Debbie Chalcraft | Group Compliance Mang. | NA |
Ms. Francesca Harris | Marketing Mang. | NA |
Mr. Patrick Lowther | Head of Strategy & Markets | NA |
Mr. Simon Oborn | Head of Property Management & Investment | NA |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes. This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API. Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.